Reaction

Difficulty In Walking reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,445 reports · 81 co-occurring drugs

As of the last recalculation, Difficulty In Walking appears in 3,445 FAERS reports alongside 81 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM GLUCONATE (PRR 26.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Calcium Gluconate	52	26.5	26.6
Raloxifene Hydrochloride	38	15.9	15.9
Teriparatide	261	15.1	15.1
Amlodipine Besylate And Benazepril Hydrochloride	17	11.2	11.2
Insulin Human	69	10.7	10.7
Tolterodine Tartrate	15	10.1	10.2
Salmeterol Xinafoate	14	9.8	9.9
Interferon Beta-1A	285	9.6	9.6
Gemfibrozil	22	8.8	8.8
Vitamin E	45	8.7	8.8
Extended Phenytoin Sodium	23	8.4	8.4
Atorvastatin Calcium	306	8.1	8.1
Celecoxib	167	8.0	8.0
Enalapril Maleate	31	7.6	7.6
Interferon Beta-1B	24	7.6	7.6
Ascorbic Acid	29	7.6	7.6
Risedronate Sodium	38	7.5	7.5
Glyburide	28	7.0	7.0
Diphenhydramine Hcl	12	6.5	6.5
Captopril	10	6.3	6.3
Losartan Potassium And Hydrochlorothiazide	12	6.3	6.3
Pioglitazone	42	5.9	5.9
Atenolol	125	5.8	5.8
Diltiazem Hydrochloride	33	5.8	5.8
Lithium Carbonate	16	5.7	5.7
Quinine	8	5.6	5.7
Valproate Sodium	19	5.6	5.6
Ziprasidone Mesylate	13	5.5	5.5
Digoxin	64	5.5	5.5
Paroxetine Hydrochloride	80	5.4	5.4
Tizanidine Hydrochloride	16	5.4	5.4
Lisinopril And Hydrochlorothiazide	9	5.3	5.3
Meperidine Hydrochloride	8	5.3	5.3
Ezetimibe And Simvastatin	13	5.2	5.2
Temozolomide	18	5.2	5.2
Ziprasidone	15	5.2	5.2
Estrogens, Conjugated	49	5.0	5.0
Conjugated Estrogens	47	4.9	4.9
Diltiazem Hydrochloride Extended-Release Tablets	9	4.8	4.8
Felodipine Extended-Release Tablets	9	4.8	4.8
Felodipine	9	4.8	4.8
Carisoprodol	15	4.8	4.8
Olanzapine Pamoate	32	4.8	4.8
Warfarin Sodium	36	4.7	4.7
Rabeprazole Sodium	21	4.7	4.7
Phenytoin	16	4.6	4.7
Thalidomide	28	4.6	4.6
Metformin Hcl	42	4.6	4.6
Levothyroxine Sodium	228	4.6	4.6
Glipizide	46	4.6	4.6
Gentamicin Sulfate	12	4.6	4.6
Amlodipine Besylate	108	4.6	4.6
Multivitamin	37	4.5	4.5
Insulin	41	4.5	4.5
Ciprofloxacin Hydrochloride And Hydrocortisone	15	4.4	4.4
Sertraline Hydrochloride	84	4.4	4.4
Divalproex Sodium	33	4.3	4.3
Carbamazepine	47	4.3	4.3
Ibuprofen And Diphenhydramine Citrate	16	4.2	4.2
Gentamicin	9	4.2	4.2
Primidone	7	4.2	4.2
Donepezil Hydrochloride	25	4.1	4.1
Terazosin Hydrochloride	6	4.1	4.1
Isosorbide Dinitrate	13	4.0	4.0
Rosuvastatin	131	4.0	4.0
Oxcarbazepine	21	3.9	3.9
Lopinavir And Ritonavir	8	3.6	3.6
Dofetilide	6	3.5	3.5
Lamivudine	17	3.3	3.3
Lisinopril And Hydrochlorothiazide Tablets	4	3.1	3.1
Loratadine And Pseudoephedrine Sulfate	4	3.0	3.0
Isopropyl Alcohol	16	2.9	2.9
Carbidopa And Levodopa	22	2.8	2.8
Atomoxetine Hydrochloride	11	2.8	2.8
Naproxen Sodium Tablet	23	2.6	2.6
Insulin Lispro	55	2.4	2.4
Medroxyprogesterone Acetate	17	2.1	2.1
Conjugated Estrogens And Medroxyprogesterone Acetate	8	2.1	2.1
Gefitinib	3	2.0	2.0
Hydrocodone Bitartrate	13	1.8	1.8
Exenatide	15	1.7	1.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.